Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District
The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms.

The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/2025.
Rare Malignant Neoplasm
OTHER: diagnosis, surgery, drugs for rare neoplasms
Incidence of different malignant rare neoplasms, Description of types of tumours, Throughout the lenght of study, an average of 10 years
Response rate (RR), Response rate to different treatments (surgery, drugs), Throughout the lenght of study, an average of 10 years|Local recurrence rate, Incidence of local recurrence, Throughout the lenght of study, an average of 10 years|Progression-free survival (PFS), Progression-free survival (PFS) assessed for different types of rare malignant neoplasms, Throughout the lenght of study, an average of 10 years|Overall survival (OS), OS assessed for different types of rare malignant neoplasms, Throughout the lenght of study, an average of 10 years
The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms.

The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/2025.